At the mechanistic level, the pro-tumorigenic functions of DLX5 have been shown to involve positive regulation of the MYC promoter in human lung cancer cells [70] as well as the IRS2 promoter, an IGFIR adapter protein, in ovarian cancer cell lines [69]. The gene discussed is MYC; the disease is lung carcinoma.